SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?

Published:2019-07 Issue: Volume:204 Page:14-22
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Gordiienko Inna,Shlapatska Larysa,Kovalevska Larysa,Sidorenko Svetlana P.^ORCID

Funder

National Academy of Sciences of Ukraine

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference111 articles.

1. Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens;Pinchouk;Anticancer Res.,1988

2. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping;Sidorenko;Neoplasma,1992

3. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes;Sidorenko;J. Immunol.,1993

4. A novel receptor involved in T-cell activation;Cocks;Nature,1995

5. CDwl50 Cluster Report;Sidorenko,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLAMF1 as a novel molecule mediating the causal association between rheumatoid arthritis and interstitial lung disease: A Mendelian randomization study combined with transcriptomics and in vivo validation;International Immunopharmacology;2024-12

2. PURE-seq identifiesEgr1as a Potential Master Regulator in Murine Aging by Sequencing Long-Term Hematopoietic Stem Cells;2024-08-14

3. HERVK-mediated regulation of neighboring genes: implications for breast cancer prognosis;Retrovirology;2024-02-22

4. SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma;Journal of Gynecologic Oncology;2024

5. STAT4, a potential predictor of prognosis, promotes CD8 T‑cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion;Oncology Reports;2023-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3